Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

NAVIGATE ESUS Investigators, J. Kunzmann, S. Oberndorfer, A. Tinchon

Research output: Journal article (peer-reviewed) › Journal article

142 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience